Requirement of clathrin heavy chain for p53-mediated transcription

Genes and Development

Volumn 20, Issue 9, 2006, Pages 1087-1099

  Enari, Masato ^a   Ohmori, Kazuji ^a   Kitabayashi, Issay ^a   Taya, Yoichi ^a  

^a NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

Author keywords

Apoptosis; Clathrin; p300; p53; p53AIP1

Indexed keywords

CLATHRIN HEAVY CHAIN; HISTONE ACETYLTRANSFERASE PCAF; PROTEIN P53; SMALL INTERFERING RNA;

ARTICLE; CELL NUCLEUS; CYTOPLASM; ENDOCYTOSIS; GENETICS; HUMAN; METABOLISM; MUTATION; PHYSIOLOGY; PROMOTER REGION; PROTEIN BINDING; TRANSACTIVATION; TUMOR CELL LINE; TUMOR SUPPRESSOR GENE;

CELL LINE, TUMOR; CELL NUCLEUS; CLATHRIN HEAVY CHAINS; CYTOPLASM; ENDOCYTOSIS; GENES, P53; HUMANS; MUTATION; P300-CBP TRANSCRIPTION FACTORS; PROMOTER REGIONS (GENETICS); PROTEIN BINDING; RNA, SMALL INTERFERING; TRANS-ACTIVATION (GENETICS); TUMOR SUPPRESSOR PROTEIN P53;

EID: 33745177802     PISSN: 08909369     EISSN: 15495477     Source Type: Journal    
DOI: 10.1101/gad.1381906     Document Type: Article

References (50)

1. Argani, P., Lui, M.Y., Couturier, J., Bouvier, R., Fournet, J.C., and Ladanyi, M. 2003. A novel CLTC-TFE3 gene fusion in pediatric renal adenocarcinoma with t(X;17)(p11.2;q23). Oncogene 22: 5374-5378. (Pubitemid 37056101)
2. Avantaggiati, M.L., Ogryzko, V., Gardner, K., Giordano, A., Levine, A.S., and Kelly, K. 1997. Recruitment of p300/CBP in p53-dependent signal pathways. Cell 89: 1175-1184. (Pubitemid 127678750)
3. Behrens, J., von Kries, J.P., Kuhl, M., Bruhn, L., Wedlich, D., Grosschedl, R., and Birchmeier, W. 1996. Functional interaction of β-catenin with the transcription factor LEF-1. Nature 382: 638-642. (Pubitemid 26268958)
4. Bourdon, J.C., Laurenzi, V.D., Melino, G., and Lane, D. 2003. p53: 25 years of research and more questions to answer. Cell Death Differ. 10: 397-399. (Pubitemid 36626350)
5. Bridge, J.A., Kanamori, M., Ma, Z., Pickering, D., Hill, D.A., Lydiatt, W., Lui, M.Y., Colleoni, G.W., Antonescu, C.R., Ladanyi, M., et al. 2001. Fusion of the ALK gene to the clathrin heavy chain gene, CLTC, in inflammatory myofibroblastic tumor. Am. J. Pathol. 159: 411-415. (Pubitemid 32751070)
6. Brummelkamp, T.R., Bernards, R., and Agami, R. 2002. A system for stable expression of short interfering RNAs in mammalian cells. Science 296: 550-553. (Pubitemid 34408678)
7. Chan, H.M. and La Thangue, N.B. 2001. p300/CBP proteins: HATs for transcriptional bridges and scaffolds. J. Cell Sci. 114: 2363-2373.
8. Chen, X., Ko, L.J., Jayaraman, L., and Prives, C. 1996. p53 levels, functional domains, and DNA damage determine the extent of the apoptotic response of tumor cells. Genes & Dev. 10: 2438-2451. (Pubitemid 26341879)
9. Chen, C.Y., Reese, M.L., Hwang, P.K., Ota, N., Agard, D., and Brodsky, F.M. 2002. Clathrin light and heavy chain interface: α-Helix binding superhelix loops via critical tryptophans. EMBO J. 21: 6072-6082. (Pubitemid 35415325)
10. Chikatsu, N., Kojima, H., Suzukawa, K., Shinagawa, A., Nagasawa, T., Ozawa, H., Yamashita, Y., and Mori, N. 2003. ALK+, CD30-, CD20- large B-cell lymphoma containing anaplastic lymphoma kinase (ALK) fused to clathrin heavy chain gene (CLTC). Mod. Pathol. 16: 828-832.
11. Conner, S.D. and Schmid, S.L. 2003. Regulated portals of entry into the cell. Nature 422: 37-44.
12. Decary, S., Decesse, J.T., Ogryzko, V., Reed, J.C., Naguibneva, I., Harel-Bellan, A., and Cremisi, C.E. 2002. The retinoblastoma protein binds the promoter of the survival gene bcl-2 and regulates its transcription in epithelial cells through transcription factor AP-2. Mol. Cell. Biol. 22: 7877-7888. (Pubitemid 35217298)
13. Dignam, J.D., Lebovitz, R.M., and Roeder, R.G. 1983. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res. 11: 1475-1489.
14. el-Deiry, W.S., Tokino, T., Velculescu, V.E., Levy, D.B., Parsons, R., Trent, J.M., Lin, D., Mercer, W.E., Kinzler, K.W., and Vogelstein, B. 1993. WAF1, a potential mediator of p53 tumor suppression. Cell 75: 817-825.
15. Gobeil, F.J., Bernier, S.G., Vazquez-Tello, A., Brault, S., Beauchamp, M.H., Quiniou, C., Marrache, A.M., Checchin, D., Sennlaub, F., Hou, X., et al. 2003. Modulation of proinflammatory gene expression by nuclear lysophosphatidic acid receptor type-1. J. Biol. Chem. 278: 38875-38883. (Pubitemid 37221787)
16. Gu, W. and Roeder, R.G. 1997. Activation of p53 sequence-specific DNA binding by acetylation of the p53 C-terminal domain. Cell 90: 595-606. (Pubitemid 27357952)
17. Heery, D.M., Kalkhoven, E., Hoare, S., and Parker, M.G. 1997. A signature motif in transcriptional co-activators mediates binding to nuclear receptors. Nature 387: 733-736. (Pubitemid 27270617)
18. Hollstein, M., Sidransky, D., Vogelstein, B., and Harris, C.C. 1991. p53 mutations in human cancers. Science 253: 49-53.
19. Honda, R., Tanaka, H., and Yasuda, H. 1997. Oncoprotein MDM2 is a ubiquitin ligase E3 for tumor suppressor p53. FEBS Lett. 420: 25-27. (Pubitemid 28037193)
20. Kirchhausen, T. 2000. Clathrin. Annu. Rev. Biochem. 69: 699-727.
21. Kitabayashi, I., Yokoyama, A., Shimizu, K., and Ohki, M. 1998. Interaction and functional cooperation of the leukemia-associated factors AML1 and p300 in myeloid cell differentiation. EMBO J. 17: 2994-3004. (Pubitemid 28254372)
22. Kitabayashi, I., Aikawa, Y., Nguyen, L.A., Yokoyama, A., and Ohki, M. 2001. Activation of AML1-mediated transcription by MOZ and inhibition by the MOZ-CBP fusion protein. EMBO J. 20: 7184-7196. (Pubitemid 34062310)
23. Levine, A.J. 1997. p53, the cellular gatekeeper for growth and division. Cell 88: 323-331.
24. Lill, N.L., Grossman, S.R., Ginsberg, D., DeCaprio, J., and Livingston, D.M. 1997. Binding and modulation of p53 by p300/CBP coactivators. Nature 387: 823-827. (Pubitemid 27270910)
25. Linke, S.P., Sengupta, S., Khabie, N., Jeffries, B.A., Buchhop, S., Miska, S., Henning, W., Pedeux, R., Wang, X.W., Hofseth, L.J., et al. 2003. p53 interacts with hRAD51 and hRAD54, and directly modulates homologous recombination. Cancer Res. 63: 2596-2605. (Pubitemid 36605201)
26. Liu, S.H., Wong, M.L., Craik, C.S., and Brodsky, F.M. 1995. Regulation of clathrin assembly and trimerization defined using recombinant triskelion hubs. Cell 83: 257-267.
27. Ljungman, M. 2000. Dial 9-1-1 for p53: Mechanisms of p53 activation by cellular stress. Neoplasia 2: 208-225. (Pubitemid 30346077)
28. Marin, M.C., Jost, C.A., Brooks, L.A., Irwin, M.S., O'Nions, J., Tidy, J.A., James, N., McGregor, J.M., Harwood, C.A., Yulug, I.G., et al. 2000. A common polymorphism acts as an intragenic modifier of mutant p53 behaviour. Nat. Genet. 25: 47-54. (Pubitemid 30257035)
29. Mihara, M., Erster, S., Zaika, A., Petrenko, O., Chittenden, T., Pancoska, P., and Moll, U.M. 2003. p53 has a direct apoptogenic role at the mitochondria. Mol. Cell 11: 577-590. (Pubitemid 36385115)
30. Oda, E., Ohki, R., Murasawa, H., Nemoto, J., Shibue, T., Yamashita, T., Tokino, T., Taniguchi, T., and Tanaka, N. 2000. Noxa, a BH3-only member of the Bcl-2 family and candidate mediator of p53-induced apoptosis. Science 288: 1053-1058. (Pubitemid 30324238)
31. Oda, K., Arakawa, H., Tanaka, T., Matsuda, K., Tanikawa, C., Mori, T., Nishimori, H., Tamai, K., Tokino, T., Nakamura, Y., et al. 2000. p53AIP1, a potential mediator of p53-dependent apoptosis, and its regulation by Ser-46-phosphorylated p53. Cell 102: 849-862.
32. Olave, I.A., Reck-Peterson, S.L., and Crabtree, G.R. 2002. Nuclear actin and actin-related proteins in chromatin remodeling. Annu. Rev. Biochem. 71: 755-781. (Pubitemid 34800234)
33. Oren, M. 2003. Decision making by p53: Life, death and cancer. Cell Death Differ. 10: 431-442. (Pubitemid 36626355)
34. Plevin, M.J., Mills, M.M., and Ikura, M. 2005. The LxxLL motif: A multifunctional binding sequence in transcriptional regulation. Trends Biochem. Sci. 30: 66-69. (Pubitemid 40187297)
35. Prives, C. and Hall, P.A. 1999. The p53 pathway. J. Pathol. 187: 112-126.
36. Rando, O.J., Zhao, K., and Crabtree, G.R. 2000. Searching for a function for nuclear actin. Trends Cell Biol. 10: 92-97.
37. Royle, S.J., Bright, N.A., and Lagnado, L. 2005. Clathrin is required for the function of the mitotic spindle. Nature 434: 1152-1157. (Pubitemid 40663496)
38. Samuels-Lev, Y., O'Connor, D.J., Bergamaschi, D., Trigiante, G., Hsieh, J.K., Zhong, S., Campargue, I., Naumovski, L., Crook, T., and Lu, X. 2001. ASPP proteins specifically stimulate the apoptotic function of p53. Mol. Cell 8: 781-794. (Pubitemid 33030212)
39. Seo, Y.R., Fishel, M.L., Amundson, S., Kelley, M.R., and Smith, M.L. 2002. Implication of p53 in base excision DNA repair: In vivo evidence. Oncogene 21: 731-737. (Pubitemid 34146285)
40. Shieh, S.Y., Ikeda, M., Taya, Y., and Prives, C. 1997. DNA damage-induced phosphorylation of p53 alleviates inhibition by MDM2. Cell 91: 325-334. (Pubitemid 27467963)
41. Shieh, S.Y., Taya, Y., and Prives, C. 1999. DNA damage-inducible phosphorylation of p53 at N-terminal sites including a novel site, Ser20, requires tetramerization. EMBO J. 18: 1815-1823. (Pubitemid 29158525)
42. Siliciano, J.D., Canman, C.E., Taya, Y., Sakaguchi, K., Appella, E., and Kastan, M.B. 1997. DNA damage induces phosphorylation of the amino terminus of p53. Genes & Dev. 11: 3471-3481. (Pubitemid 28023968)
43. Tanaka, H., Arakawa, H., Yamaguchi, T., Shiraishi, K., Fukuda, S., Matsui, K., Takei, Y., and Nakamura, Y. 2000. A ribonucleotide reductase gene involved in a p53-dependent cell-cycle checkpoint for DNA damage. Nature 404: 42-49. (Pubitemid 30143125)
44. Tarapore, P. and Fukasawa, K. 2002. Loss of p53 and centrosome hyperamplification. Oncogene 21: 6234-6240.
45. Taylor, J.A., Li, Y., He, M., Mason, T., Mettlin, C., Vogler, W.J., Maygarden, S., and Liu, E. 1996. p53 mutations in bladder tumors from arylamine-exposed workers. Cancer Res. 56: 294-298. (Pubitemid 26026357)
46. Vogelstein, B., Lane, D., and Levine, A.J. 2000. Surfing the p53 network. Nature 408: 307-310.
47. Vousden, K.H. and Lu, X. 2002. Live or let die: The cell's response to p53. Nat. Rev. Cancer 2: 594-604. (Pubitemid 37328926)
48. Wargnier, A., Legros-Maida, S., Bosselut, R., Bourge, J.F., Lafaurie, C., Ghysdael, C.J., Sasportes, M., and Paul, P. 1995. Identification of human granzyme B promoter regulatory elements interacting with activated T-cell-specific proteins: Implication of Ikaros and CBF binding sites in promoter activation. Proc. Natl. Acad. Sci. 92: 6930-6934.
49. Zhu, J., Zhou, W., Jiang, J., and Chen, X. 1998. Identification of a novel p53 functional domain that is necessary for mediating apoptosis. J. Biol. Chem. 273: 13030-13036. (Pubitemid 28246867)
50. Zhu, J., Jiang, J., Zhou, W., Zhu, K., and Chen, X. 1999. Differential regulation of cellular target genes by p53 devoid of the PXXP motifs with impaired apoptotic activity. Oncogene 18: 2149-2155. (Pubitemid 29178584)